KAROLINSKA INSTITUTE, HAGALUND, SWEDEN. A group of researchers have recently developed a drug that will not just prevent type 2 diabetes but it will also reduce the development of the disease. Type 2 diabetes is connected with metabolic syndrome such as hypertension and obesity most of the time. Before the development of the research, there was no known drug that could possibly reverse the development of type 2 diabetes.
In general, diabetes is only one of the many common types of diseases around the world. Currently, there are millions of people around the world who are suffering from type 2 diabetes. The disease may also be the consequential result of an unhealthy lifestyle. The recent development in the research definitely tells us that there is hope for its cure.
Dr. Andrew Nash is the head of the study and the Senior Vice President of Research at CSL. His team of researchers were able to create a drug that keeps fat deposits from forming around the muscle cells and the heart. VEGF-B protein is responsible in forming and transporting fat deposits in the human body. The drug acts by blocking VEGF signaling which is called 2H10. It normalizes the blood sugar level and sensible to insulin once again. It shows very promising results which will surely benefit millions of people around the world with type 2 diabetes.
| Invention | Type 2 Diabetes Drug (2H10) |
|---|---|
| Organization | Karolinska Institute, Hagalund, Sweden |
| Researcher | Dr. Andrew Nash & Team |
| Field(s) | Diabetes, Type 2 Diabetes, 2H10, VEGF-B protein |
| Further Information | Doctor Tipster |
